Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05549661
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2022-09-19
Brief Title:
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-19
First Submit QC Date:
September 19 2022
Study First Post Date:
2022-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-19
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL